Articles

A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility

Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain;Institute of Biomedical Research of Salamanca (IBSAL), Spain;National Medicines Institute, Warsaw, Poland
Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain;Institute of Biomedical Research of Salamanca (IBSAL), Spain
Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain;Institute of Biomedical Research of Salamanca (IBSAL), Spain
Hematology Department, Hospital 12 de Octubre, CNIO, Complutense University, CIBERONC, Madrid, Spain
Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain;Institute of Biomedical Research of Salamanca (IBSAL), Spain;Hospital Universitario de Salamanca, CIBERONC, Spain
Hospital Germans Trias i Pujol, Barcelona, Spain
Hospital Clinic, Barcelona, Spain
Hospital 12 de Octubre, Madrid, Spain
Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain
Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain;Institute of Biomedical Research of Salamanca (IBSAL), Spain;Hospital Universitario de Salamanca, CIBERONC, Spain
Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain;Institute of Biomedical Research of Salamanca (IBSAL), Spain;Hospital Universitario de Salamanca, CIBERONC, Spain
Vol. 103 No. 5 (2018): May, 2018 https://doi.org/10.3324/haematol.2017.181628